Author

Gavin Turner

University of PennsylvaniaORCID 0000-0002-2810-0236Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Robert J. LeeiD· 3 shared Ryan M. CareyiD· 3 shared Sarah M. SywanycziD· 3 shared Brianna L. HilliD· 2 shared Kyle PoleniD· 2 shared Lily HuangiD· 2 shared Zoey A. MilleriD· 2 shared Leilei Hao· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Robert J. LeeORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TAS2R10 Suppresses ABCG2 Transporter-Associated Chemoresistance and Enhances Cisplatin Sensitivity in Head and Neck Squamous Cell Carcinoma

Lily Huang, Sarah M. Sywanycz, Priyanka Sahu, Leilei Hao, Kyle Polen, Gavin Turner, Zoey A. Miller, Robert J. Lee, Ryan M. Carey

This study shows caffeine enhances cisplatin sensitivity in HNSCC by increasing TAS2R10 expression and reducing ABCG2 expression.

bioRxiv · Jul 27, 2026 · PreprintCancer Biology

T2R5 agonist phendione decreases cell viability and induces apoptosis in head and neck squamous cell carcinoma

Sarah M. Sywanycz, Brianna L. Hill, Zoey A. Miller, Gavin Turner, Lily Huang, Kyle Polen, Robert J. Lee, Ryan M. Carey

Phendione, a T2R5 agonist, reduces cell viability and induces apoptosis in HNSCC cells and tumor samples, with T2R5 expression linked to better survival in HNSCC.

Molecular Cancer Therapeutics · Nov 7, 2025Peer-reviewedCancer Biology

Quercetin as a Bitter Taste Receptor Agonist with Anticancer Effects in Head and Neck Cancer Cells

Gavin Turner, Sarah M. Sywanycz, Brianna L. Hill, Robert D. Wardlow, Robert J. Lee, Ryan M. Carey

This study shows quercetin activates T2R14 in HNSCC cells, causing calcium responses, reduced viability, and mitochondrial depolarization.

Nutrients · Oct 14, 2025Peer-reviewedCancer Biology